These patients “commonly experience nausea, vomiting, pain, anorexia and fatigue related to cancer-directed therapy or to their cancer itself, that may be treated with medical marijuana or synthetic cannabinoids,” authors write.
With 89 per cent of the patients receiving chemotherapy and 56 per cent undergoing primary treatment, more than 70 per cent reported improvement in nausea/vomiting compared to 36 per cent who were using it for pain relief. That said, 71 per cent of the 41 patients remaining in the latest study at follow-up reported that using MM had improved at least one of their symptoms.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: nationalpost - 🏆 10. / 80 Read more »